Gout - Nicola Dalbeth

Date Published: 
Monday, November 28, 2016

Professor Nicola Dalbeth shares an update on the management of gout. Nicola is a rheumatologist at the University of Auckland and Auckland District Health Board. She is a founding member of the Māori Gout Action Group, chair of the Atlas of Health Care Variance Gout Expert Advisory Group and was clinical lead advisor for the gout clinical pathways and bpac gout treatment guidelines.


  • Do genetics play a larger factor in gout than we previously thought?
  • Attitudes around the disease.
  • New technologies for diagnosing gout.
  • Patient education and management.
  • Pharmacological management of gout – acute flares and urate-lowering therapies.
  • Serum urate levels… How low?
  • Should we measure serum urate levels during an acute attack?
  • Which patients should we start on urate lowering therapy?
  • Can we start urate lowering therapy during an acute flare?
  • Allopurinol dosage levels and prescribing guidelines.
  • Options for second line therapies and prescribing.
  • Management of acute gout flares.
  • Take home messages.


Nicola Dalbeth

To find out more about Nicola Click here.

Recognition of Learning Activities

Don't forget to log your time with The Royal New Zealand College of General Practitioners portal for recognition of learning activities.

RNZCGP website


This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.